- Staat
- IL
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 07.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Guillain-Barre syndrome
Immunisation reaction
Symptomtext
Patient called our pharmacy on 7/1/2022 and talked to pharmacist on duty. She said that she was diagnosed with Guillian-Barre Syndrome and her physician said it was caused from the shingles vaccine she received on 5-7-22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- unknown
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 14.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Contusion
Injection site erythema
Injection site pain
Injection site swelling
Inflammation
Syncope
Myalgia
Pain
Symptomtext
Pt fainted the morning after receiving IMZ. She also had local inflammation, but this resolved within a few days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 09.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Bacterial infection
Culture positive
Erythema
Pain
Paraesthesia
Sensitive skin
Skin discolouration
Skin erosion
Skin warm
Skin wound
Swelling
Symptomtext
Started with redness and swelling and extreme pain hot to touch. Later bnecame an open raw area with the skin turning black extreme pain, burning and needle like pain. Very sensitive to touch, Went to clinic weekly until Sept 2022. Picture included in medical records
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- culture July 13 light growth Nonsporeforming Gram Positive Rod
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- na
- Andere Medikamente
- Celexa 20 mg Crestor 20mg
- Allergien
- sulfa
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 04.08.2022
- Impfdatum
- 31.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Heart rate decreased
Hypotension
Injection site pain
Mobility decreased
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Hypotension-Severe, Additional Details: Caregiver also reported decreased heart rate and could not move arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Arthralgia
Asthenia
Chills
Headache
Laboratory test
Mobility decreased
Muscle spasms
Nausea
Pain in extremity
Pyrexia
Sleep disorder
Symptomtext
Night of vaccination, I began to get in the middle of the night, feverish. Could not get out of bed. I had a severe headache, i was shivering, and my arm was killing me. I was so nauseous, couldn't take anything for my head. I could not get out of bed. Finally around 5-6 am, i managed to get out the bed. I had cramps and stomach pain. After that, I had achiness in my knees. Today is the first day that my arm is not sore. I didnt even want to go out yesterday due to weakness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- 1,0
- Labordaten
- Yes, I went to the hospital and had tests and labs done.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Food allergy to shellfish , Unable to take morphine, codine, cintinal.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 27.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Extra dose administered
Fatigue
Headache
Inflammation
Myalgia
Nausea
Vertigo
Symptomtext
I did receive the newest Covid Booster, #5 for me, about a week prior to getting the Shingrix vaccine. I had no side effects from the Covid Booster at all. After receiving the Shingrix, My temperature started to rise within a few hours. After two days, my temp went up to 99.8. Today is day 4 and my temp is down to 98.4 which is still up form my usual 97.2. The most important thing that I want to report is that on day 3, I started having very severe dizziness and nausea. I have had probably every vaccine including the Hep B due to being in the dental field and I have never had anything throw me totally out of commission. I could not move my head without experiencing vertigo. I also had muscle aches and pains as well as fatigue and a constant headache, but those symptoms do not alarm me. Although I am not supposed to take NSAIDS, I have been taking Aleve since I read that the Shingrix can cause inflammation in the sensory system. I am seeing my neurologist on Monday and I will be discussing this with him since I have never had vertigo until now. I am thinking that the risks of taking the second Shingrix do not support the second dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Low Thyroid, HBP, neuropathy from brain surgery to remove cavernous angioma
- Andere Medikamente
- Gabapentin, Levothyroxine, Bystolic
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 29.08.2022
- Impfdatum
- 23.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Biopsy skin normal
Injection site erythema
Injection site irritation
Symptomtext
PATIENT STATED THAT THE SITE OF INJECTION WAS RED AND IRRITATED AND IT SEEMED LOWER THAN USUAL. COUPLE OF MONTHS LATER SHE WENT TO A DERMATOLOGIST AND VOLUNTEERED TO HAVE A "SURVEY" AS BIOPSY PROCEDURE AT THE SITE AND AFTER THAT IT GOT WORST AND STILL RED AS OF TODAY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- PER PT, THE BIOPSY RESULT CAME BACK "NEGATIVE"
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LEXAPRO
- Allergien
- KNA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 18.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site erythema
Rash
Symptomtext
Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Additional Details: Patient developed a red rash on her arm and it had some bruising as well she went to the doctor and he gave her cephalexin to take incase of skin infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
rash on abdomen, arm, leg. Ongoing since vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- DM, CAD
- Andere Medikamente
- cymbalta, maxzide, synjardy XR, lisinopril, propranolol, tresiba, crestor, diltiazem
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 15.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Blood glucose increased
Fatigue
Myalgia
Symptomtext
Patient described feeling weak, with muscle aches, and tiredness. He also described significantly increased blood sugar. He normally uses 0.8 unit/hr in his pump, but had to increase by 20-25 units over the course of the day to keep blood sugar controlled.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes, chronic pain, hypothyroidism
- Andere Medikamente
- Humalog, Levothyroxine, Norco, Tramadol
- Allergien
- Codeine, Penicillins
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 07.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Fatigue
Pain in extremity
Peripheral swelling
Symptomtext
Fatigue onset 24 hours after vaccine and lasted 2-3 days. Located erythema, swelling and pain to arm about 24-48 hours afterward and lasted for about a week
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Eczema
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Flank pain
Injection site erythema
Injection site hypoaesthesia
Injection site induration
Renal function test
Tenderness
Symptomtext
Right deltoid erythema and induration 10cm x 6 cm. Tender to the touch. Mild numbness to injection site. Right flank pain. May take Tylenol or Ibuprofen
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Flank pain
- Hospital-Tage
- -
- Labordaten
- Renal panel 4/27/22
- Aktuelle Erkrankungen
- Allergic bilateral eye conjunctivitis
- Vorgeschichte
- MDD, GAD, Tobacco use, PTSD
- Andere Medikamente
- Current Outpatient Medications on File Prior to Visit Medication Sig Dispense Refill ? azelastine (OPTIVAR) 0.05 % ophthalmic solution Place 1 Drop into both eyes 2 (two) times daily 6 mL 5 ? diclofenac sodium (VOLTAREN) 75 mg DR tablet Tak
- Allergien
- Codeine CodeineItchingNot Specified1/9/2015Deletion Reason: Hydrocodone-acetaminophen Hydrocodone-acetaminophenItchingNot Specified11/26/2012Caused itching over body and stomach painDeletion Reason: Propoxyphene N-acetaminophen Propoxyphene N-acetaminophenNot SpecifiedNot Verified11/26/2012Itching over body and stomach ache itchingDeletion Reason: Propoxyphene Napsylate Propoxyphene NapsylateItchingNot Specified1/9/2015
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 25.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Diarrhoea
Product storage error
Sinusitis
Symptomtext
Four days following administration of the patient's second dose of Shingrix, we were made aware that the vaccine was deemed "not viable" due to a temperature excursion that occurred earlier in the week. The patient doesn't recall experiencing any adverse effects immediately following vaccination. The patient reports experiencing diarrhea from April 18-22, and April 24th. She attributes this to a keto diet that she has recently adopted. Recently she has been experiencing sinus infection symptoms, which she attributes to allergies from pollen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None known.
- Vorgeschichte
- High cholesterol, pain, high blood pressure.
- Andere Medikamente
- Celecoxib 100mg daily; gemfibrozil 1200mg daily; losartan 25mg daily.
- Allergien
- None known.
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 04.04.2022
- Impfdatum
- 27.03.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Pain
Pruritus
Swelling
Symptomtext
itching, swelling, soreness, pain, nausea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HYPERTENSION
- Andere Medikamente
- METOPROLOL, DULOXETINE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fear of injection
Immediate post-injection reaction
Injection site warmth
Symptomtext
PT HAD IMMEDIATE DIZZINESS POST VACCINATION AND WARM SENSATION AT INJECTION SITE; PT WAS ASKED TO REMAIN SEATED AND GIVEN COLD COMPRESS FOR INJECTIOIN SITE, FOLLOWED AT AT 645PM ON 3/16/22 - STATED THAT SHE WAS JUST ACTUALLY AFRAID OF NEEDLES AND OTHERWISE DOING OK
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- dementia and blood pressure
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Feeling hot
Rash
Swelling
Symptomtext
Redness, swelling, Heat and rash.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 22.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Gait disturbance
Hypoaesthesia
Symptomtext
The patient called around 5:20PM on 06/23/2022 stating that she had left leg numbness and was having trouble walking. She stated that she was dragging her foot around all day. She stated that she had taken some Tylenol, but nothing was helping. She received the shot around 5PM on 06/22/2022 and stated that her signs/symptoms began upon awakening on 06/23/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Gait disturbance
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Tylenol (mentioned on the phone)
- Allergien
- Biaxin, bees
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product preparation issue
Symptomtext
administered only the adjuvant portion of shingrix, not the antigen; administered only the adjuvant portion of shingrix, not the antigen; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 4NX5J, expiry date 9th June 2023) for prophylaxis. On 13th April 2022, the patient received the 1st dose of Shingrix. On 13th April 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 12-MAY-2022 Reporter's Comment: Health care professional (HCP) reported a patient was administered only the adjuvant portion of Shingrix and not the antigen. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up. Additional Supportive Information: The patient received only the adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 11.05.2022
- Impfdatum
- 05.05.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product preparation issue
Symptomtext
received a dose of Adjuvant only; received a dose of Adjuvant only; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number 4NX5J, expiry date 9th June 2023) for prophylaxis. On 5th May 2022, the patient received Shingrix. On 5th May 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 5-MAY-2022 Reporter's Comment: The reporter was a Medical assistant. The patient received a dose of adjuvant only of Shingrix instead of the reconstituted vaccine. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The patient received Shingrix adjuvant only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 10.05.2022
- Impfdatum
- 05.05.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product preparation issue
Symptomtext
The medical assistant only admin. the liquid part of the shot not the powder . Medical assistant did not mix the two together.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- -
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
3 patients received a dose that was exposed to low temperature excursion; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 4NX5J, expiry date 9th June 2023) for prophylaxis. On 4th April 2022, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 5th April 2022 Reporter's Comments: The pharmacist reported the patient received a dose of Shingrix that was exposed to low temperature excursion of 31.5 degree F. The reporter did not consent to follow-up. Additional Supportive Information: As the Shingrix was exposed to low temperature excursion, which led to incorrect storage of drug. The case has been linked with the case US2022060314 and US2022060315 reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022060314:same reporter US-GLAXOSMITHKLINE-US2022060315:same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 01.08.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
administered with a third dose; 1st dose of shingrix on Feb 2019, and 2nd dose on August 2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number 4NX5J, expiry date 9th June 2023) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date in February 2019). On 4th April 2022, the patient received the 3rd dose of Shingrix. In August 2021, the patient received the 2nd dose of Shingrix. In August 2021, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On 4th April 2022, the patient experienced extra dose administered. On an unknown date, the outcome of the drug dose administration interval too long and extra dose administered were unknown. Additional Information: GSK Receipt Date: 04-APR-2022 Reporter's comments: The patient was administered with a third dose of Shingrix on the day of reporting. The reporter explained that, after getting medical history of patient's vaccination, they got that the patient received only one dose. Then, he administered what he believed was the 2nd dose of Shingrix on the day of reporting. During the day, the pharmacist received new information and was that the patient was administered with 1st dose of shingrix on February 2019 and 2nd dose on August 2021. The reporter consented to follow up. Additional Supportive Information: The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. On the day of reporting, patient received 3rd dose of Shingrix, which led to extra dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 01.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
PATIENT RECEIVED A 2ND BOOSTER DOSE OF PFIZER COVID VACCINE WHEN SHE WANTED A 2ND DOSE OF SHINGRIX VACCINE. THERE WAS VERBAL MISCOMMUNICATION WITH THIS INCIDENT WHEN PERFORMING OUR 2ND CHECK TO VERIFY CORRECT VACCINE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- diabetes
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 14.03.2022
- Impfdatum
- 14.03.2022
- Beginn
- 14.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Circumstance or information capable of leading to medication error
No adverse event
Product administered to patient of inappropriate age
Symptomtext
no adverse events occurred. the error was a misinterpretation of immunocompromised. i thought being that the patient is a diabetic she qualified for the new 19 and above recommendation
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- diabetic
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -